phorbolol myristate acetate has been researched along with Colitis, Ulcerative in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chayama, K; Hanaoka, R; Hatakeyama, T; Onitake, T; Shimamoto, M; Tanaka, S; Ueno, Y; Yoshioka, K | 1 |
1 other study(ies) available for phorbolol myristate acetate and Colitis, Ulcerative
| Article | Year |
|---|---|
Selective decrease in colonic CD56(+) T and CD161(+) T cells in the inflamed mucosa of patients with ulcerative colitis.
Topics: Adult; Aged; Anti-Inflammatory Agents; Antigens, Surface; Azathioprine; CD56 Antigen; Colitis, Ulcerative; Female; Humans; Immunosuppressive Agents; Interleukin-10; Intestinal Mucosa; Ionomycin; Ionophores; Lectins, C-Type; Male; Middle Aged; NK Cell Lectin-Like Receptor Subfamily B; Prednisolone; T-Lymphocyte Subsets; Tetradecanoylphorbol Acetate | 2007 |